Robert Guenard, Ph.D.

Associate Vice President, CMC Analytics

Robert leads analytical method development, validation, and transfer activities with a digital-first operating model to support clinical development and regulatory approval readiness at Parabilis Medicines, working to bring the power of data sciences and digital technologies to the CMC space. He is a well-seasoned professional in product development and production with expertise in analytical chemistry, data science, and strategy and has a strong passion for modernizing how molecules from discovery are transformed into life-changing therapies for patients.

Prior to Parabilis, Robert was the Head of Data Sciences and Digital Transformation at Pfizer Development. He also held many strategic technical leadership roles in analytical chemistry, data sciences, and digital at Biogen, Merck (MSD) and Dow Chemical.

Robert graduated with a Ph.D. in Analytical Chemistry from the University of Florida and a B.S. in Chemistry from UMass Lowell.